Cancer News and Research

Latest Cancer News and Research

Plant virus-derived treatment shows promise against metastatic cancers

An experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in mice, shows a new study from the University of California San Diego.

13 May 2024

Research unlocks the role of macrophages in cancer relapse

Researchers from the Cancer Science Institute of Singapore at the National University of Singapore (NUS), have achieved breakthroughs in understanding relapse after chemotherapy for a type of cancer known as diffuse large B-cell lymphoma (DLBCL).

13 May 2024

Study reveals latest cancer trends in Canada

The number of cancer cases and deaths in Canada is expected to increase because of a growing and aging population, but the overall rates of people being diagnosed with and dying from cancer will continue to decline, according to the latest cancer trends research in CMAJ.

13 May 2024

New insights into Chaga mushroom's mechanisms for fighting oral cancer

The mechanisms behind the anti-tumor activity of Chaga mushroom extracts in HSC-4 human oral cancer cells.

13 May 2024

First responders, veterans hail benefits of psychedelic drugs as California debates legalization

Wade Trammell recalls the time he and his fellow firefighters responded to a highway crash in which a beer truck rammed into a pole, propelling the truck's engine through the cab and into the driver's abdomen.

13 May 2024

Long-term Finnish study explores the association between premature menopause and mortality

Women who enter menopause before the age of 40 are more likely to die young, but may lower their risk with hormone therapy, according to research presented at the 26th European Congress of Endocrinology in Stockholm.

13 May 2024

Questions about childhood weight can help identify increased mortality risk in adults with obesity

Being asked whether you considered yourself a normal weight, plumper or thinner as a child when attending a doctor's appointment as an adult might appear like a very strange question to ask, but new research being presented at this year's European Congress on Obesity in Venice, Italy (12-15 May) suggests that such questions can help identify increased mortality risk in adults living with obesity.

13 May 2024

Enhanced weight loss outcomes with GLP-1 analogues and bupropion/naltrexone combination

A study explores the additive effects of combining GLP-1 analog with bupropion/naltrexone on weight loss, finding potential benefits even for those initially unresponsive to monotherapy.

13 May 2024

Mainz Biomed to unveil breakthrough early cancer detection study results at DDW 2024

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, will present an analysis from its eAArly DETECT study at Digestive Disease Week (DDW) 2024 in Washington D.C. from May 18th to May 21st. DDW is recognized as a premier forum for the latest advancements in gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.

11 May 2024

Scripps Research professor emeritus John Johnson selected as member of the National Academy of Sciences

Scripps Research professor emeritus John Johnson, PhD, has been elected to the National Academy of Sciences—one of the highest honors given to scientists.

11 May 2024

NHS still faces waiting list challenges

Commenting on the publication today of the NHS monthly performance statistics, Tim Gardner, Assistant Director of Policy at the Health Foundation, said.

11 May 2024

Expanding treatment horizons for hypermutated urothelial carcinomas beyond immunotherapy

A new editorial paper was published in Oncoscience (Volume 11) on April 25, 2024, entitled, "Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy."

10 May 2024

Study spotlights differences based on race and gender in melanoma diagnosis, outcomes

Melanoma, an aggressive form of skin cancer that accounts for 75% of all skin-cancer-related deaths, is often detected later in people with darker skin complexions -; and the consequences can be devastating, a Mayo Clinic study reveals.

10 May 2024

DoD grant awarded for investigating alternative polyadenylation in prostate cancer

A team led by Dr. Eddie Imada, assistant professor of research in pathology and laboratory medicine, has been awarded a three-year, $1.5 million United States Department of Defense grant for research on a cellular process called alternative polyadenylation and its role in prostate cancer.

10 May 2024

Chemotherapy linked to physical decline in older women with high-risk breast cancer

A UCLA-led study suggests women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function.

10 May 2024

Researchers discover a 'training program' driving parietal cell development

Common conditions such as indigestion and heartburn as well as peptic ulcers, autoimmune gastritis and stomach and esophageal cancers have one thing in common – they involve disruptions of the normal activity of parietal cells (PCs) in the stomach, the only cells in the body that produce acid.

10 May 2024

New collaboration to combat river blindness and lymphatic filariasis

Prof. Achim Hoerauf, Director of the Institute of Medical Microbiology, Immunology and Parasitology at the University Hospital Bonn (UKB), and his team have succeeded in collaborating with the Department of Pharmaceutical Technology and Biopharmacy at the University of Bonn and the Helmholtz Center for Infection Research (HZI), to enter into a partnership with the Japanese pharmaceutical company Eisai for the further development of the antibiotic corallopyronin A (CorA) as a treatment for the neglected tropical diseases river blindness and lymphatic filariasis and to raise a large amount of funding.

10 May 2024

FDA-approved TIVDAK®: Targeting tissue factor in cervical cancer

On April 29th, 2024, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor (TF) for the treatment of patients with recurrent or metastatic cervical cancer who have progressed on or after chemotherapy. This marks a significant advancement in the therapeutic landscape for cervical cancer, highlighting the potential of antibody-drug conjugates (ADCs) in oncology.

From Sino Biological Inc. 10 May 2024

Can living in flood-prone areas increase your risk of death?

The long-term effects of flooding on mortality.

10 May 2024

Frequent salt addition at the table increases gastric cancer risk by 41%

Addition of salt to food at the table and risk of developing stomach cancer.

10 May 2024

Cancer News and Research

Latest Cancer News and Research

Plant virus-derived treatment shows promise against metastatic cancers

Research unlocks the role of macrophages in cancer relapse

Study reveals latest cancer trends in Canada

New insights into Chaga mushroom's mechanisms for fighting oral cancer

First responders, veterans hail benefits of psychedelic drugs as California debates legalization

Long-term Finnish study explores the association between premature menopause and mortality

Questions about childhood weight can help identify increased mortality risk in adults with obesity

Enhanced weight loss outcomes with GLP-1 analogues and bupropion/naltrexone combination

Mainz Biomed to unveil breakthrough early cancer detection study results at DDW 2024

Scripps Research professor emeritus John Johnson selected as member of the National Academy of Sciences

NHS still faces waiting list challenges

Expanding treatment horizons for hypermutated urothelial carcinomas beyond immunotherapy

Study spotlights differences based on race and gender in melanoma diagnosis, outcomes

DoD grant awarded for investigating alternative polyadenylation in prostate cancer

Chemotherapy linked to physical decline in older women with high-risk breast cancer

Researchers discover a 'training program' driving parietal cell development

New collaboration to combat river blindness and lymphatic filariasis

FDA-approved TIVDAK®: Targeting tissue factor in cervical cancer

Can living in flood-prone areas increase your risk of death?

Frequent salt addition at the table increases gastric cancer risk by 41%

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Cancer News and Research

Latest Cancer News and Research

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in